BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1382105)

  • 1. Importance of endothelial VCAM-1 for inflammatory leukocytic infiltration in vivo.
    Pelletier RP; Ohye RG; Vanbuskirk A; Sedmak DD; Kincade P; Ferguson RM; Orosz CG
    J Immunol; 1992 Oct; 149(7):2473-81. PubMed ID: 1382105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of endothelial VCAM-1 expression in murine cardiac grafts. Expression of allograft endothelial VCAM-1 can be manipulated with antagonist of IFN-alpha or IL-4 and is not required for allograft rejection.
    Bergese SD; Huang EH; Pelletier RP; Widmer MB; Ferguson RM; Orosz CG
    Am J Pathol; 1995 Jul; 147(1):166-75. PubMed ID: 7541609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
    Bishop DK; Shelby J; Eichwald EJ
    Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the endothelial adhesion molecule VCAM in murine cardiac allograft rejection.
    Orosz CG; van Buskirk A; Sedmak DD; Kincade P; Miyake K; Pelletier RP
    Immunol Lett; 1992 Mar; 32(1):7-12. PubMed ID: 1379979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of endothelial VCAM-1 expression in murine cardiac grafts. Roles for TNF and IL4.
    Bergese S; Pelletier R; Vallera D; Widmer M; Orosz C
    Am J Pathol; 1995 Apr; 146(4):989-98. PubMed ID: 7536398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppression to cardiac allografts and soluble antigens by anti-vascular cellular adhesion molecule-1 and anti-very late antigen-4 monoclonal antibodies.
    Isobe M; Suzuki J; Yagita H; Okumura K; Yamazaki S; Nagai R; Yazaki Y; Sekiguchi M
    J Immunol; 1994 Dec; 153(12):5810-8. PubMed ID: 7527450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft endothelial VCAM-1 is not necessary for acute cardiac allograft rejection in mice.
    Bergese SD; Pelletier RP; Ferguson RM; Orosz CG
    Transplant Proc; 1995 Feb; 27(1):480-1. PubMed ID: 7533417
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of inflammatory endothelial changes, including VCAM-1 expression, in murine cardiac grafts.
    Pelletier RP; Morgan CJ; Sedmak DD; Miyake K; Kincade PW; Ferguson RM; Orosz CG
    Transplantation; 1993 Feb; 55(2):315-20. PubMed ID: 7679529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody to anti-VCAM-1 interferes with murine cardiac allograft rejection.
    Pelletier R; Ohye R; Kincade P; Ferguson R; Orosz C
    Transplant Proc; 1993 Feb; 25(1 Pt 1):839-41. PubMed ID: 7679845
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts.
    Cosimi AB; Conti D; Delmonico FL; Preffer FI; Wee SL; Rothlein R; Faanes R; Colvin RB
    J Immunol; 1990 Jun; 144(12):4604-12. PubMed ID: 1972162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of adhesion molecules on the endothelia of rejecting cardiac allografts.
    Lemström K; Koskinen P; Häyry P
    J Heart Lung Transplant; 1995; 14(2):205-13. PubMed ID: 7779837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cell adhesion molecules on limbal and neovascular endothelium in corneal inflammatory neovascularization.
    Zhu SN; Dana MR
    Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1427-34. PubMed ID: 10359324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of mice with anti-CD3 mAb induces endothelial vascular cell adhesion molecule-1 expression.
    Bergese SD; Pelletier RP; Ohye RG; Vallera DA; Orosz CG
    Transplantation; 1994 Mar; 57(5):711-7. PubMed ID: 7511256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial activation and chronic allograft rejection.
    Orosz CG
    Clin Transplant; 1994 Jun; 8(3 Pt 2):299-303. PubMed ID: 7520304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with anti-vascular cell adhesion molecule 1 monoclonal antibody induces long-term murine cardiac allograft acceptance.
    Orosz CG; Ohye RG; Pelletier RP; Van Buskirk AM; Huang E; Morgan C; Kincade PW; Ferguson RM
    Transplantation; 1993 Aug; 56(2):453-60. PubMed ID: 7689262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of accelerated coronary atherosclerosis with short-term blockade of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in a heterotopic murine model of heart transplantation.
    Suzuki J; Isobe M; Yamazaki S; Horie S; Okubo Y; Sekiguchi M
    J Heart Lung Transplant; 1997 Nov; 16(11):1141-8. PubMed ID: 9402514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An endothelial cell adhesion protein for monocytes recognized by monoclonal antibody IG9. Expression in vivo in inflamed human vessels and atherosclerotic human and Watanabe rabbit vessels.
    Calderon TM; Factor SM; Hatcher VB; Berliner JA; Berman JW
    Lab Invest; 1994 Jun; 70(6):836-49. PubMed ID: 8015288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Deazaadenosine prevents leukocyte invasion by suppression of adhesion molecule expression during acute cardiac allograft rejection: involvement of apoptotic cell death.
    Fingerhuth H; Hölschermann H; Grimm H; Tillmanns H; Haberbosch W; Braun-Dullaeus RC; Stadlbauer TH
    J Heart Lung Transplant; 2004 Aug; 23(8):970-8. PubMed ID: 15312827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT-1 and AP-1 decoy oligonucleotide therapy delays acute rejection and prolongs cardiac allograft survival.
    Hölschermann H; Stadlbauer TH; Wagner AH; Fingerhuth H; Muth H; Rong S; Güler F; Tillmanns H; Hecker M
    Cardiovasc Res; 2006 Aug; 71(3):527-36. PubMed ID: 16822491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.